RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Peter R. Hoffmann to Anti-Inflammatory Agents

Back to Details
This is a "connection" page, showing publications Peter R. Hoffmann has written about Anti-Inflammatory Agents.
Peter R. Hoffmann
Connection Strength
0.281
Anti-Inflammatory Agents
  1. Schoenefuss F, Hoffmann P. Serum ?-globulin and albumin concentrations predict secondary loss of response to anti-TNFa in inflammatory bowel disease patients. Eur J Gastroenterol Hepatol. 2019 Dec; 31(12):1563-1568.
    View in: PubMed
    Score: 0.154
  2. Zhu C, Zhang S, Song C, Zhang Y, Ling Q, Hoffmann PR, Li J, Chen T, Zheng W, Huang Z. Selenium nanoparticles decorated with Ulva lactuca polysaccharide potentially attenuate colitis by inhibiting NF-?B mediated hyper inflammation. J Nanobiotechnology. 2017 Mar 07; 15(1):20.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support